首页 > 最新文献

Gene最新文献

英文 中文
PRDM14 promotes the bovine somatic stem cell reprogramming through enhancing oxidative phosphorylation at the initial stage PRDM14通过在初始阶段增强氧化磷酸化促进牛体细胞干细胞重编程。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-10 Epub Date: 2025-12-23 DOI: 10.1016/j.gene.2025.149978
Qingqing Wei , Wenhui Li , Guina Cui , Yiliang Xu , Shaorong Gao
Bovine induced pluripotent stem cells (biPSCs), which can be obtained through somatic cells reprogramming have multiple potential applications in human disease, regeneration medicine and biotechnical animal breeding. However, the low reprogramming efficiency and poorly exploration of the mechanism underlying the somatic cells reprogramming in cattle restricted the applications of biPSCs. Here, we reported the transcription factor PR-domain containing protein 14 (PRDM14) was highly expressed in bovine fetal testis and intestine. And the expression of PRDM14 showed the lowest level in bovine embryonic fibroblasts (BEF), increased on day 3 and day 18, and finally reached the highest level in induced pluripotent stem cells (iPSCs) during the reprogramming induced by OCT4, SOX2, KLF4 and MYC (OSKM). In a gain-of-function assay, we showed that PRDM14 was able to enhance the efficiency of reprogramming from BEF in conjunction with bovine OSKM. While, silencing of PRDM14 inhibited the reprogramming efficiency of BEF. The bovine iPSCs derived from OSKM plus PRDM14 displayed normal karyotype, expressed pluripotent markers and could differentiated into three germ layers in vitro. Transcriptome analysis of cells at the early, median and late reprogramming stages revealed that several genes involved in oxidative phosphorylation (OXPHOS) are upregulated on day 3 when OXPHOS burst occurs, while downregulated on day 15 when OXPHOS transmits to glycolysis, by ectopic expression of PRDM14. RT-qPCR and ATP content detection further confirmed that PRDM14 could improve somatic cells reprogramming by enhancing OXPHOS at the early stage. Additionally, forced expression of PRDM14 in OSKM-induced biPSCs showed that it upregulates the expression of key pluripotency gene NANOG but downregulates LIN28, DNA methylation genes DNMT1/3B and DNA demethylation genes TET1/2/3. Altogether, our study uncovers PRDM14 exemplifies a key transcription factor required for the reacquisition of pluripotency in bovine somatic cells and the maintenance of bovine iPSCs identity.
牛诱导多能干细胞(Bovine induced pluripotent stem cells, biPSCs)可通过体细胞重编程获得,在人类疾病、再生医学和生物技术动物育种等方面具有多种潜在的应用前景。然而,牛体细胞重编程效率低,对体细胞重编程机制的探索不足,限制了bipsc的应用。在此,我们报道了转录因子pr结构域蛋白14 (PRDM14)在牛胎儿睾丸和肠道中高表达。在OCT4、SOX2、KLF4和MYC (OSKM)诱导的重编程过程中,PRDM14在牛胚胎成纤维细胞(BEF)中的表达水平最低,在第3天和第18天均有所升高,最终在诱导多能干细胞(iPSCs)中达到最高表达水平。在功能增益分析中,我们发现PRDM14能够提高牛OSKM与BEF的重编程效率。而PRDM14的沉默抑制了BEF的重编程效率。由OSKM + PRDM14分离得到的牛iPSCs核型正常,表达多能性标记,体外分化为3种胚层。对重编程早期、中期和晚期细胞的转录组分析显示,在氧化磷酸化(OXPHOS)爆发发生的第3天,一些参与氧化磷酸化(OXPHOS)的基因上调,而在氧化磷酸化(OXPHOS)转化为糖酵解的第15天,PRDM14的异位表达下调。RT-qPCR和ATP含量检测进一步证实了PRDM14可以通过早期增强OXPHOS来促进体细胞重编程。此外,在oskm诱导的bipsc中强制表达PRDM14表明,它上调了关键多能基因NANOG的表达,下调了LIN28、DNA甲基化基因DNMT1/3B和DNA去甲基化基因TET1/2/3的表达。总之,我们的研究揭示了PRDM14是牛体细胞重新获得多能性和维持牛iPSCs特性所需的关键转录因子。
{"title":"PRDM14 promotes the bovine somatic stem cell reprogramming through enhancing oxidative phosphorylation at the initial stage","authors":"Qingqing Wei ,&nbsp;Wenhui Li ,&nbsp;Guina Cui ,&nbsp;Yiliang Xu ,&nbsp;Shaorong Gao","doi":"10.1016/j.gene.2025.149978","DOIUrl":"10.1016/j.gene.2025.149978","url":null,"abstract":"<div><div>Bovine induced pluripotent stem cells (biPSCs), which can be obtained through somatic cells reprogramming have multiple potential applications in human disease, regeneration medicine and biotechnical animal breeding. However, the low reprogramming efficiency and poorly exploration of the mechanism underlying the somatic cells reprogramming in cattle restricted the applications of biPSCs. Here, we reported the transcription factor PR-domain containing protein 14 (<em>PRDM14</em>) was highly expressed in bovine fetal testis and intestine. And the expression of <em>PRDM14</em> showed the lowest level in bovine embryonic fibroblasts (BEF), increased on day 3 and day 18, and finally reached the highest level in induced pluripotent stem cells (iPSCs) during the reprogramming induced by <em>OCT4</em>, <em>SOX2</em>, <em>KLF4</em> and <em>MYC</em> (OSKM). In a gain-of-function assay, we showed that <em>PRDM14</em> was able to enhance the efficiency of reprogramming from BEF in conjunction with bovine OSKM. While, silencing of <em>PRDM14</em> inhibited the reprogramming efficiency of BEF. The bovine iPSCs derived from OSKM plus <em>PRDM14</em> displayed normal karyotype, expressed pluripotent markers and could differentiated into three germ layers in vitro. Transcriptome analysis of cells at the early, median and late reprogramming stages revealed that several genes involved in oxidative phosphorylation (OXPHOS) are upregulated on day 3 when OXPHOS burst occurs, while downregulated on day 15 when OXPHOS transmits to glycolysis, by ectopic expression of <em>PRDM14</em>. RT-qPCR and ATP content detection further confirmed that <em>PRDM14</em> could improve somatic cells reprogramming by enhancing OXPHOS at the early stage. Additionally, forced expression of <em>PRDM14</em> in OSKM-induced biPSCs showed that it upregulates the expression of key pluripotency gene <em>NANOG</em> but downregulates <em>LIN28</em>, DNA methylation genes <em>DNMT1</em>/<em>3B</em> and DNA demethylation genes <em>TET1</em>/<em>2</em>/<em>3</em>. Altogether, our study uncovers <em>PRDM14</em> exemplifies a key transcription factor required for the reacquisition of pluripotency in bovine somatic cells and the maintenance of bovine iPSCs identity.</div></div>","PeriodicalId":12499,"journal":{"name":"Gene","volume":"982 ","pages":"Article 149978"},"PeriodicalIF":2.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro expression and seroreactivity of Toxoplasma gondii GRA1 protein encoded by unmodified and nucleoside-modified mRNA constructs 未修饰和核苷修饰的刚地弓形虫gr1蛋白的体外表达及血清反应性。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-10 Epub Date: 2025-12-16 DOI: 10.1016/j.gene.2025.149965
Mehmet Nadir Şahinci , Mert Döşkaya , Muhammet Karakavuk , Seren Kaplan , Gizem Mutlu , Tuğçe Gizem Perçin , Sedef Erkunt Alak , Özlem Günay-Esiyok , Aytül Gül Mete , Aysu Değirmenci Döşkaya , Ayşe Gülten Kantarcı , Adnan Yüksel Gürüz , Hüseyin Can
Toxoplasmosis is an infectious parasitic disease caused by Toxoplasma gondii, with a global seroprevalence estimated to affect more than one-third of the human population. T. gondii can be a serious health concern for pregnant women and immunocompromised patients. Currently, there is no effective and safe vaccine for humans. However, mRNA technology is a promising platform to develop efficient and safe vaccines against toxoplasmosis. Therefore, we designed nucleoside-modified and unmodified mRNA vaccine transcripts expressing T. gondii recombinant GRA1 protein and analyzed their in vitro protein expression profile as well as potential immunogenicity using IFAT, Western blot, and ELISA. Moreover, to compare translational efficiency, poly-A tail was extended with an extra ∼150 bp in addition to the existing ∼120 bp poly-A tail in two distinct mRNA designs. The results showed that all four mRNA constructs expressed rGRA1 protein in HEK293T cells. However, mRNA constructs with extended poly-A tails exhibited reduced expression level of rGRA1 protein compared to other mRNA vaccine transcripts. Additionally, unmodified mRNA construct with or without extended poly-A tail yielded significantly higher protein expression compared to nucleoside-modified mRNA constructs through ELISA using anti-polyhis antibody (P<0.05). Western blot showed that rGRA1 protein expressed by all four mRNA constructs reacted strongly with T. gondii IgG seropositive mice sera. Furthermore, ELISA revealed that rGRA1 proteins derived from unmodified and nucleoside-modified mRNA constructs formed significantly stronger immune complexes with T. gondii IgG antibodies compared to negative controls (P<0.05). These data suggest that both unmodified and nucleosidemodified mRNA constructs expressing rGRA1 protein have potential as vaccine candidates and warrant further investigation for development of an mRNA-based vaccine against toxoplasmosis. However, encapsulation of the produced mRNA constructs in LNPs and in vivo studies are required to validate these preliminary results.
弓形虫病是由刚地弓形虫引起的一种传染性寄生虫病,其全球血清患病率估计影响到三分之一以上的人口。弓形虫对孕妇和免疫功能低下的人来说可能是一个严重的健康问题。目前,还没有针对人类的有效疫苗。然而,mRNA技术是开发高效、安全的弓形虫病疫苗的一个有前途的平台。因此,我们设计了核苷修饰和未修饰的编码密码子优化的弓形虫gr1蛋白的mRNA疫苗转录本,并利用IFAT、Western blot和ELISA分析了它们的体外蛋白表达谱和表达蛋白的潜在免疫原性。此外,为了比较翻译效率,在两种mRNA设计中,除了现有的~ 120 bp poly-A尾外,还将聚腺苷化(poly -A)尾长度额外延长了~ 150 bp。结果表明,所有mRNA构建体在HEK293T细胞中均表达重组GRA1蛋白。然而,与其他mRNA疫苗转录物相比,具有延伸poly-A尾部的mRNA构建物表现出rGRA1蛋白表达水平降低。此外,与核苷修饰的mRNA结构相比,未修饰的mRNA结构产生了显著更高的蛋白质表达(P
{"title":"In vitro expression and seroreactivity of Toxoplasma gondii GRA1 protein encoded by unmodified and nucleoside-modified mRNA constructs","authors":"Mehmet Nadir Şahinci ,&nbsp;Mert Döşkaya ,&nbsp;Muhammet Karakavuk ,&nbsp;Seren Kaplan ,&nbsp;Gizem Mutlu ,&nbsp;Tuğçe Gizem Perçin ,&nbsp;Sedef Erkunt Alak ,&nbsp;Özlem Günay-Esiyok ,&nbsp;Aytül Gül Mete ,&nbsp;Aysu Değirmenci Döşkaya ,&nbsp;Ayşe Gülten Kantarcı ,&nbsp;Adnan Yüksel Gürüz ,&nbsp;Hüseyin Can","doi":"10.1016/j.gene.2025.149965","DOIUrl":"10.1016/j.gene.2025.149965","url":null,"abstract":"<div><div>Toxoplasmosis is an infectious parasitic disease caused by <em>Toxoplasma gondii</em>, with a global seroprevalence estimated to affect more than one-third of the human population. <em>T. gondii</em> can be a serious health concern for pregnant women and immunocompromised patients. Currently, there is no effective and safe vaccine for humans. However, mRNA technology is a promising platform to develop efficient and safe vaccines against toxoplasmosis. Therefore, we designed nucleoside-modified and unmodified mRNA vaccine transcripts expressing <em>T. gondii</em> recombinant GRA1 protein and analyzed their <em>in vitro</em> protein expression profile as well as potential immunogenicity using IFAT, Western blot, and ELISA. Moreover, to compare translational efficiency, poly-A tail was extended with an extra ∼150 bp in addition to the existing ∼120 bp poly-A tail in two distinct mRNA designs. The results showed that all four mRNA constructs expressed rGRA1 protein in HEK293T cells. However, mRNA constructs with extended poly-A tails exhibited reduced expression level of rGRA1 protein compared to other mRNA vaccine transcripts. Additionally, unmodified mRNA construct with or without extended poly-A tail yielded significantly higher protein expression compared to nucleoside-modified mRNA constructs through ELISA using anti-polyhis antibody (P&lt;0.05). Western blot showed that rGRA1 protein expressed by all four mRNA constructs reacted strongly with <em>T. gondii</em> IgG seropositive mice sera. Furthermore, ELISA revealed that rGRA1 proteins derived from unmodified and nucleoside-modified mRNA constructs formed significantly stronger immune complexes with <em>T. gondii</em> IgG antibodies compared to negative controls (P&lt;0.05). These data suggest that both unmodified and nucleosidemodified mRNA constructs expressing rGRA1 protein have potential as vaccine candidates and warrant further investigation for development of an mRNA-based vaccine against toxoplasmosis. However, encapsulation of the produced mRNA constructs in LNPs and <em>in vivo</em> studies are required to validate these preliminary results.</div></div>","PeriodicalId":12499,"journal":{"name":"Gene","volume":"982 ","pages":"Article 149965"},"PeriodicalIF":2.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ginsenoside Rg1 delays chronological aging in a yeast model via SSE1-Mediated mitophagy 人参皂苷Rg1通过sse1介导的线粒体自噬延缓酵母模型的时间顺序衰老
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-10 Epub Date: 2025-12-24 DOI: 10.1016/j.gene.2025.149986
Ze Yao , Ming Lu , Chunshuang Li , Xiang Li , Hui Shang , Songtao Bie
Ginsenoside Rg1 (Rg1), an active compound in Panax ginseng C. A. Meyer (ginseng), has shown potential to ameliorate age-related cell damage and extend lifespan in multiple model organisms. However, the precise molecular mechanisms of its anti-aging effects remain unclear. In this study, we explore the anti-aging mechanisms of ginsenoside Rg1, focusing on its impact on mitophagy in Saccharomyces cerevisiae. Using propidium iodide staining, we found that Rg1 extends the chronological lifespan (CLS) of yeast cells. Further analyses revealed that Rg1 enhances mitochondrial function and antioxidant capacity in yeast cells by inducing mitophagy. Moreover, RNA-Seq and bioinformatics analyses identified the molecular chaperone SSE1 as a key target of Rg1. SSE1 knockout strain demonstrated that Rg1 enhances mitochondrial function and antioxidant capacity through SSE1-dependent mitophagy, thereby extending cell lifespan. Collectively, we concluded that Rg1 exerts its anti-aging effects through SSE1-mediated mitophagy. This study advances our understanding of Rg1-mediated mitophagy and mitochondrial regulation via SSE1, offering a foundation for the rational design of targeted anti-aging treatments.
人参皂苷Rg1 (Rg1)是人参中的一种活性化合物,在多种模式生物中显示出改善与年龄相关的细胞损伤和延长寿命的潜力。然而,其抗衰老作用的确切分子机制尚不清楚。在本研究中,我们探讨了人参皂苷Rg1的抗衰老机制,重点研究了其对酿酒酵母线粒体自噬的影响。通过碘化丙啶染色,我们发现Rg1延长了酵母细胞的时间寿命(CLS)。进一步的分析表明,Rg1通过诱导线粒体自噬来增强酵母细胞的线粒体功能和抗氧化能力。此外,RNA-Seq和生物信息学分析发现分子伴侣SSE1是Rg1的关键靶点。SSE1敲除菌株表明,Rg1通过依赖SSE1的线粒体自噬增强线粒体功能和抗氧化能力,从而延长细胞寿命。综上所述,我们认为Rg1通过sse1介导的线粒体自噬发挥其抗衰老作用。本研究加深了我们对rg1介导的线粒体自噬和SSE1介导的线粒体调控的认识,为合理设计靶向抗衰老治疗提供了基础。
{"title":"Ginsenoside Rg1 delays chronological aging in a yeast model via SSE1-Mediated mitophagy","authors":"Ze Yao ,&nbsp;Ming Lu ,&nbsp;Chunshuang Li ,&nbsp;Xiang Li ,&nbsp;Hui Shang ,&nbsp;Songtao Bie","doi":"10.1016/j.gene.2025.149986","DOIUrl":"10.1016/j.gene.2025.149986","url":null,"abstract":"<div><div>Ginsenoside Rg1 (Rg1), an active compound in <em>Panax ginseng</em> C. A. Meyer (ginseng), has shown potential to ameliorate age-related cell damage and extend lifespan in multiple model organisms. However, the precise molecular mechanisms of its anti-aging effects remain unclear. In this study, we explore the anti-aging mechanisms of ginsenoside Rg1, focusing on its impact on mitophagy in <em>Saccharomyces cerevisiae</em>. Using propidium iodide staining, we found that Rg1 extends the chronological lifespan (CLS) of yeast cells. Further analyses revealed that Rg1 enhances mitochondrial function and antioxidant capacity in yeast cells by inducing mitophagy. Moreover, RNA-Seq and bioinformatics analyses identified the molecular chaperone <em>SSE1</em> as a key target of Rg1. <em>SSE1</em> knockout strain demonstrated that Rg1 enhances mitochondrial function and antioxidant capacity through <em>SSE1</em>-dependent mitophagy, thereby extending cell lifespan. Collectively, we concluded that Rg1 exerts its anti-aging effects through <em>SSE1</em>-mediated mitophagy. This study advances our understanding of Rg1-mediated mitophagy and mitochondrial regulation via <em>SSE1</em>, offering a foundation for the rational design of targeted anti-aging treatments.</div></div>","PeriodicalId":12499,"journal":{"name":"Gene","volume":"982 ","pages":"Article 149986"},"PeriodicalIF":2.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel tRNA-derived fragment tRF-Val-CAC-008 as a diagnostic biomarker and pyroptosis regulator in LSCC 一种新的trna衍生片段tRF-Val-CAC-008作为LSCC的诊断生物标志物和焦亡调节剂。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-10 Epub Date: 2025-12-17 DOI: 10.1016/j.gene.2025.149967
Hongxia Deng , Dong Ye , Shijie Qiu , Shuang Ye , Chongchang Zhou , Shuai Fang , Yuna Zhang , Shanshan Gu

Objective

Laryngeal cancer is one of the most common malignant tumors of the head and neck, with laryngeal squamous cell carcinoma (LSCC) being the most significant pathological type. Transfer RNA-derived fragments (tRFs) fragments have been implicated in tumor progression through diverse regulatory mechanisms. This study examined the diagnostic value and role of tRF-Val-CAC-008 in LSCC.

Methods

Levels of tRF-Val-CAC-008 were quantified in LSCC tissues, plasma, saliva, and cells using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). The diagnostic value of tRF-Val-CAC-008 was then assessed using the receiver operating characteristic (ROC) curve. LSCC cells were transfected with mimics or inhibitors of tRF-Val-CAC-008, which increased or decreased its level accordingly. Cell proliferation was evaluated using EdU and the cell counting kit-8 (CCK-8) assays. The level of lactate dehydrogenase (LDH) in LSCC cells was measured using an LDH release assay. Pyroptosis-associated proteins were analyzed by Western blotting (WB).

Results

tRF-Val-CAC-008 exhibited significantly higher expression levels in LSCC tissues, plasma and saliva. This higher expression correlated with its pro-proliferative effects and suppression of pyroptosis observed in vitro. In LSCC cells, tRF-Val-CAC-008 mimics promoted cell proliferation and reduced LDH secretion. The expression of gasdermin E (GSDME) and caspase-3 proteins was also decreased by tRF-Val-CAC-008 mimics, which in turn regulated pyroptosis. The ROC curves suggest that combined plasma and saliva tRF-Val-CAC-008 can serve as a diagnostic marker to distinguish LSCC patients from healthy participants.

Conclusions

The study concluded that tRF-Val-CAC-008 could act as a diagnostic marker for LSCC; it promotes tumor growth by suppressing pyroptosis and promoting cell proliferation.
目的:喉癌是头颈部最常见的恶性肿瘤之一,喉鳞癌(喉鳞癌)是最重要的病理类型。转移rna衍生片段(tRFs)片段通过多种调节机制与肿瘤进展有关。本研究探讨了tRF-Val-CAC-008在LSCC中的诊断价值和作用。方法:采用实时定量逆转录聚合酶链反应(qRT-PCR)技术,定量检测LSCC组织、血浆、唾液和细胞中tRF-Val-CAC-008的水平。然后用受试者工作特征(ROC)曲线评估tRF-Val-CAC-008的诊断价值。用tRF-Val-CAC-008的模拟物或抑制剂转染LSCC细胞,可相应提高或降低其水平。用EdU和细胞计数试剂盒-8 (CCK-8)测定细胞增殖情况。乳酸脱氢酶(LDH)释放法测定LSCC细胞乳酸脱氢酶(LDH)水平。Western blotting (WB)分析热释热相关蛋白。结果:tRF-Val-CAC-008在LSCC组织、血浆和唾液中的表达水平明显升高。这种高表达与体外观察到的促增殖作用和抑制焦亡有关。在LSCC细胞中,tRF-Val-CAC-008模拟促进细胞增殖并减少LDH分泌。tRF-Val-CAC-008模拟物也降低了gasdermin E (GSDME)和caspase-3蛋白的表达,从而调节焦亡。ROC曲线提示血浆和唾液tRF-Val-CAC-008可作为区分LSCC患者和健康受试者的诊断指标。结论:tRF-Val-CAC-008可作为LSCC的诊断标志物;它通过抑制焦亡和促进细胞增殖来促进肿瘤生长。
{"title":"A novel tRNA-derived fragment tRF-Val-CAC-008 as a diagnostic biomarker and pyroptosis regulator in LSCC","authors":"Hongxia Deng ,&nbsp;Dong Ye ,&nbsp;Shijie Qiu ,&nbsp;Shuang Ye ,&nbsp;Chongchang Zhou ,&nbsp;Shuai Fang ,&nbsp;Yuna Zhang ,&nbsp;Shanshan Gu","doi":"10.1016/j.gene.2025.149967","DOIUrl":"10.1016/j.gene.2025.149967","url":null,"abstract":"<div><h3>Objective</h3><div>Laryngeal cancer is one of the most common malignant tumors of the head and neck, with laryngeal squamous cell carcinoma (LSCC) being the most significant pathological type. Transfer RNA-derived fragments (tRFs) fragments have been implicated in tumor progression through diverse regulatory mechanisms. This study examined the diagnostic value and role of tRF-Val-CAC-008 in LSCC.</div></div><div><h3>Methods</h3><div>Levels of tRF-Val-CAC-008 were quantified in LSCC tissues, plasma, saliva, and cells using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). The diagnostic value of tRF-Val-CAC-008 was then assessed using the receiver operating characteristic (ROC) curve. LSCC cells were transfected with mimics or inhibitors of tRF-Val-CAC-008, which increased or decreased its level accordingly. Cell proliferation was evaluated using EdU and the cell counting kit-8 (CCK-8) assays. The level of lactate dehydrogenase (LDH) in LSCC cells was measured using an LDH release assay. Pyroptosis-associated proteins were analyzed by Western blotting (WB).</div></div><div><h3>Results</h3><div>tRF-Val-CAC-008 exhibited significantly higher expression levels in LSCC tissues, plasma and saliva. This higher expression correlated with its pro-proliferative effects and suppression of pyroptosis observed in vitro. In LSCC cells, tRF-Val-CAC-008 mimics promoted cell proliferation and reduced LDH secretion. The expression of gasdermin E (GSDME) and caspase-3 proteins was also decreased by tRF-Val-CAC-008 mimics, which in turn regulated pyroptosis. The ROC curves suggest that combined plasma and saliva tRF-Val-CAC-008 can serve as a diagnostic marker to distinguish LSCC patients from healthy participants.</div></div><div><h3>Conclusions</h3><div>The study concluded that tRF-Val-CAC-008 could act as a diagnostic marker for LSCC; it promotes tumor growth by suppressing pyroptosis and promoting cell proliferation.</div></div>","PeriodicalId":12499,"journal":{"name":"Gene","volume":"982 ","pages":"Article 149967"},"PeriodicalIF":2.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel candidate missense variant in the catalytic domain of USP26 associated with asthenoteratozoospermia USP26催化区域的一个新的候选错义变体与弱异卵精子症相关。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-10 Epub Date: 2025-12-19 DOI: 10.1016/j.gene.2025.149945
Seyedeh Zahra Mousavi , Masomeh Askari , Ken McElreavey , Anu Bashamboo , Najmeh Salehi , Mandana Rastari , Zeynab Rokhsattalab , Bahram Mohammad Soltani , Mehdi Totonchi

Introduction

Teratozoospermia, characterized by abnormal sperm morphology, is a significant factor contributing to the male infertility. Deubiquitinating enzymes play a crucial role in controlling protein synthesis and degradation during spermatogenesis.

Methods

Whole exome sequencing (WES) and the following insilico analysis were performed to detect the associated variant with asthenoteratozoospermia in a consanguineous Iranian family with two affected brothers.

Results

WES identified a novel candidate hemizygous missense mutation (chrX-132161044 T > G:NM_031907.2:c.1205A > C, p.Asn402Thr) in the catalytic domain of the USP26 (Ubiquitin-Specific Peptidase 26) deubiquitinating enzyme in two affected siblings. The USP26 encodes a testis-specific deubiquitinating enzyme which is necessary for normal spermatogenesis and may influence male fertility. The mutation changes asparagine 402 (N) into threonine (T) and was co-segregated with phenotype in other available family members. In-silico predictions indicate that the N402T change not only leads to the absence of a hydrogen bond between the mutant N402T and F430 residues but also causes a reduction in USP26 protein stability, potentially resulting in defects in USP26 enzymatic activity.

Conclusions

Our findings support a potential role for USP26 variants contributing to asthenoteratozoospermia.
摘要畸形精子症是导致男性不育的重要因素,其特征是精子形态异常。去泛素化酶在控制精子发生过程中蛋白质的合成和降解中起着至关重要的作用。方法:采用全外显子组测序(WES)和以下计算机分析方法检测一个有两个兄弟患病的伊朗近亲家庭中与弱异卵精子症相关的变异。结果:WES鉴定出一种新的候选半合子错义突变(chrX-132161044 T > G:NM_031907.2:c)。1205A > C, p.Asn402Thr)在两个患病兄弟姐妹的USP26(泛素特异性肽酶26)去泛素化酶的催化区域。USP26编码睾丸特异性去泛素化酶,这是正常精子发生所必需的,并可能影响男性生育能力。该突变将天冬酰胺402 (N)转变为苏氨酸(T),并与其他可用家族成员的表型共分离。硅预测表明,N402T的变化不仅导致突变体N402T和F430残基之间缺乏氢键,而且还导致USP26蛋白稳定性降低,可能导致USP26酶活性缺陷。结论:我们的研究结果支持USP26变异对弱异卵精子症的潜在作用。
{"title":"A novel candidate missense variant in the catalytic domain of USP26 associated with asthenoteratozoospermia","authors":"Seyedeh Zahra Mousavi ,&nbsp;Masomeh Askari ,&nbsp;Ken McElreavey ,&nbsp;Anu Bashamboo ,&nbsp;Najmeh Salehi ,&nbsp;Mandana Rastari ,&nbsp;Zeynab Rokhsattalab ,&nbsp;Bahram Mohammad Soltani ,&nbsp;Mehdi Totonchi","doi":"10.1016/j.gene.2025.149945","DOIUrl":"10.1016/j.gene.2025.149945","url":null,"abstract":"<div><h3>Introduction</h3><div>Teratozoospermia, characterized by abnormal sperm morphology, is a significant factor contributing to the male infertility. Deubiquitinating enzymes play a crucial role in controlling protein synthesis and degradation during spermatogenesis.</div></div><div><h3>Methods</h3><div>Whole exome sequencing (WES) and the following insilico analysis were performed to detect the associated variant with asthenoteratozoospermia in a consanguineous Iranian family with two affected brothers.</div></div><div><h3>Results</h3><div>WES identified a novel candidate hemizygous missense mutation (chrX-132161044 T &gt; G:NM_031907.2:c.1205A &gt; C, p.Asn402Thr) in the catalytic domain of the <em>USP26</em> (Ubiquitin-Specific Peptidase 26) deubiquitinating enzyme in two affected siblings. The <em>USP26</em> encodes a testis-specific deubiquitinating enzyme which is necessary for normal spermatogenesis and may influence male fertility. The mutation changes asparagine 402 (N) into threonine (T) and was co-segregated with phenotype in other available family members. In-silico predictions indicate that the N402T change not only leads to the absence of <em>a</em> hydrogen bond between the mutant N402T and F430 residues but also causes a reduction in <em>USP26</em> protein stability, potentially resulting in defects in <em>USP26</em> enzymatic activity.</div></div><div><h3>Conclusions</h3><div>Our findings support a potential role for <em>USP26</em> variants contributing to asthenoteratozoospermia.</div></div>","PeriodicalId":12499,"journal":{"name":"Gene","volume":"982 ","pages":"Article 149945"},"PeriodicalIF":2.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145803957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to “Association of polymorphisms in the interleukin-4 gene with response to hepatitis B vaccine and susceptibility to hepatitis B virus infection: a meta-analysis” [Gene 525 (2013) 35–40] “白细胞介素-4基因多态性与乙型肝炎疫苗反应和乙型肝炎病毒感染易感性的关联:meta分析”[基因525(2013)35-40]。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-05 Epub Date: 2025-12-17 DOI: 10.1016/j.gene.2025.149947
Wei Cui, Cui-Ming Sun, Bao-Cheng Deng, Pei Liu
{"title":"Retraction notice to “Association of polymorphisms in the interleukin-4 gene with response to hepatitis B vaccine and susceptibility to hepatitis B virus infection: a meta-analysis” [Gene 525 (2013) 35–40]","authors":"Wei Cui,&nbsp;Cui-Ming Sun,&nbsp;Bao-Cheng Deng,&nbsp;Pei Liu","doi":"10.1016/j.gene.2025.149947","DOIUrl":"10.1016/j.gene.2025.149947","url":null,"abstract":"","PeriodicalId":12499,"journal":{"name":"Gene","volume":"981 ","pages":"Article 149947"},"PeriodicalIF":2.4,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to “Correlation between TGF-β1-509 C>T polymorphism and risk of digestive tract cancer in a meta-analysis for 21,196 participants” [Gene 505 (2012) 66-74] 撤回“一项21,196名参与者的meta分析中TGF-β1-509 C>T多态性与消化道癌风险的相关性”[Gene 505(2012) 66-74]。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-05 Epub Date: 2025-12-17 DOI: 10.1016/j.gene.2025.149948
Jian Min Zhang , Xi Jun Cui , Yun Qiang Xia , Sen Guo
{"title":"Retraction notice to “Correlation between TGF-β1-509 C>T polymorphism and risk of digestive tract cancer in a meta-analysis for 21,196 participants” [Gene 505 (2012) 66-74]","authors":"Jian Min Zhang ,&nbsp;Xi Jun Cui ,&nbsp;Yun Qiang Xia ,&nbsp;Sen Guo","doi":"10.1016/j.gene.2025.149948","DOIUrl":"10.1016/j.gene.2025.149948","url":null,"abstract":"","PeriodicalId":12499,"journal":{"name":"Gene","volume":"981 ","pages":"Article 149948"},"PeriodicalIF":2.4,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Under the dual hit: genetic and phenotypic analysis of a Han family with severe adolescent cirrhosis from the convergence of Wilson’s disease and favism 双重打击下:一个汉族家族由Wilson病和favism合并的严重青少年肝硬化的遗传和表型分析。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-05 Epub Date: 2025-12-16 DOI: 10.1016/j.gene.2025.149953
Yu-qin Xie , Zi-yan Xu , Hong Lin , Li-jun Xie , Jie-wei Luo , Li-jun Zhang , Zhi-hai Zheng
Hepatolenticular degeneration (HLD, MIM:277900) is an autosomal recessive disorder characterized by excessive copper accumulation in hepatocytes, leading to hepatic and neurological abnormalities, hepatocellular injury, neurodegeneration, and copper deposition in the cornea. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common genetic cause of hemolytic anemia, which can be triggered by chronic conditions, drugs, food, or infections, and exhibits highly variable severity. In some cases, multiple genetic factors may collectively influence disease presentation and progression. This study reports a proband who developed abnormal liver function at age 20. Four years later, she exhibited severe jaundice, liver dysfunction, serous effusions, anemia, and Kayser–Fleischer rings, leading to diagnoses including decompensated cirrhosis, splenomegaly, suspected HLD, hemolytic anemia, portal hypertension, hypoproteinemia, low T3 syndrome, primary peritonitis, and gallstones with cholecystitis. Genetic screening identified two pathogenic heterozygous variants in ATP7B (NM_000053.4): c.2128G > A (p.G710S) in exon 8 and c.525dupA (p.V176Sfs*28) in exon 2, together forming a compound heterozygous mutation. Additionally, a heterozygous mutation in G6PD (NM_001360016.2), c.1388G > A (p.R463H) in exon 12, was found. Family members carrying the G6PD variant showed recurrent benign jaundice or remained asymptomatic. A heterozygous missense variant of uncertain significance, c.205C > T (p.R69C), was also detected in exon 3 of STEAP3 (NM_182915.3), a gene linked to hypochromic microcytic anemia with iron overload type 2 (MIM#615234). This rare variant was predicted to be deleterious by in silico tools, suggesting possible genetic cosegregation.
SWISS-MODEL analysis indicated that these variants may alter the three-dimensional structures of the copper-transporting ATPase and G6PD proteins, potentially impairing function—particularly the frameshift mutation p.V176Sfs*28. We hypothesize that the accumulation of multiple pathogenic genetic factors resulted in a “double-hit” effect, leading to the patient’s severe phenotypes, including advanced liver cirrhosis and hemolytic anemia. Elucidating such multi-gene “double-hit” mechanisms may enhance the understanding of gene–gene interactions in complex diseases.
肝豆状核变性(HLD, MIM:277900)是一种常染色体隐性遗传病,其特征是肝细胞内铜积聚过多,导致肝脏和神经异常、肝细胞损伤、神经变性和角膜内铜沉积。葡萄糖-6-磷酸脱氢酶(G6PD)缺乏是溶血性贫血最常见的遗传原因,可由慢性疾病、药物、食物或感染引发,并且表现出高度可变的严重程度。在某些情况下,多种遗传因素可能共同影响疾病的表现和进展。本研究报告了一个先证者在20岁时出现肝功能异常。4年后,患者出现严重黄疸、肝功能障碍、浆液积液、贫血、Kayser-Fleischer环,诊断为失代偿性肝硬化、脾肿大、疑似HLD、溶血性贫血、门脉高压、低蛋白血症、低T3综合征、原发性腹膜炎、胆结石合并胆囊炎。遗传筛选在ATP7B (NM_000053.4)中发现两个致病杂合变异体:位于第8外显子的c.2128G > A (p.G710S)和位于第2外显子的c.525dupA (p.V176Sfs*28),共同形成一个复合杂合突变。此外,在G6PD (NM_001360016.2)的第12外显子中发现了c.1388G > a (p.R463H)的杂合突变。携带G6PD变异的家庭成员表现为复发性良性黄疸或无症状。在STEAP3 (NM_182915.3)的外显子3中也检测到一种不确定意义的杂合错义变异c.205C > T (p.R69C),这是一种与低色素小细胞贫血伴铁过载型2 (mim# 615234)相关的基因。这种罕见的变异被计算机工具预测为有害的,表明可能存在遗传共分离。SWISS-MODEL分析表明,这些变异可能改变铜转运ATPase和G6PD蛋白的三维结构,潜在地损害功能,特别是移码突变p.V176Sfs*28。我们假设多种致病遗传因素的积累导致“双重打击”效应,导致患者出现严重的表型,包括晚期肝硬化和溶血性贫血。阐明这种多基因“双重打击”机制可能会增强对复杂疾病中基因-基因相互作用的理解。
{"title":"Under the dual hit: genetic and phenotypic analysis of a Han family with severe adolescent cirrhosis from the convergence of Wilson’s disease and favism","authors":"Yu-qin Xie ,&nbsp;Zi-yan Xu ,&nbsp;Hong Lin ,&nbsp;Li-jun Xie ,&nbsp;Jie-wei Luo ,&nbsp;Li-jun Zhang ,&nbsp;Zhi-hai Zheng","doi":"10.1016/j.gene.2025.149953","DOIUrl":"10.1016/j.gene.2025.149953","url":null,"abstract":"<div><div>Hepatolenticular degeneration (HLD, MIM:277900) is an autosomal recessive disorder characterized by excessive copper accumulation in hepatocytes, leading to hepatic and neurological abnormalities, hepatocellular injury, neurodegeneration, and copper deposition in the cornea. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common genetic cause of hemolytic anemia, which can be triggered by chronic conditions, drugs, food, or infections, and exhibits highly variable severity. In some cases, multiple genetic factors may collectively influence disease presentation and progression. This study reports a proband who developed abnormal liver function at age 20. Four years later, she exhibited severe jaundice, liver dysfunction, serous effusions, anemia, and Kayser–Fleischer rings, leading to diagnoses including decompensated cirrhosis, splenomegaly, suspected HLD, hemolytic anemia, portal hypertension, hypoproteinemia, low T3 syndrome, primary peritonitis, and gallstones with cholecystitis. Genetic screening identified two pathogenic heterozygous variants in ATP7B (NM_000053.4): c.2128G &gt; A (p.G710S) in exon 8 and c.525dupA (p.V176Sfs*28) in exon 2, together forming a compound heterozygous mutation. Additionally, a heterozygous mutation in G6PD (NM_001360016.2), c.1388G &gt; A (p.R463H) in exon 12, was found. Family members carrying the G6PD variant showed recurrent benign jaundice or remained asymptomatic. A heterozygous missense variant of uncertain significance, c.205C &gt; T (p.R69C), was also detected in exon 3 of STEAP3 (NM_182915.3), a gene linked to hypochromic microcytic anemia with iron overload type 2 (MIM#615234). This rare variant was predicted to be deleterious by in silico tools, suggesting possible genetic cosegregation.</div><div>SWISS-MODEL analysis indicated that these variants may alter the three-dimensional structures of the copper-transporting ATPase and G6PD proteins, potentially impairing function—particularly the frameshift mutation p.V176Sfs*28. We hypothesize that the accumulation of multiple pathogenic genetic factors resulted in a “double-hit” effect, leading to the patient’s severe phenotypes, including advanced liver cirrhosis and hemolytic anemia. Elucidating such multi-gene “double-hit” mechanisms may enhance the understanding of gene–gene interactions in complex diseases.</div></div>","PeriodicalId":12499,"journal":{"name":"Gene","volume":"981 ","pages":"Article 149953"},"PeriodicalIF":2.4,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trolline attenuates diabetic vascular injury by regulating SLC7A11-mediated ferroptosis and mitochondrial dysfunction troline通过调节slc7a11介导的铁下垂和线粒体功能障碍减轻糖尿病血管损伤。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-05 Epub Date: 2025-12-17 DOI: 10.1016/j.gene.2025.149968
Wenbo Liu , Cuifang Lu , Bin Yang , Ying Liu , Jie Yan , Tingyu Song , Xiaofei Wang

Aims

This study investigated the therapeutic potential of Trolline, a natural compound, for alleviating high-glucose (HG)-induced vascular endothelial ferroptosis and mitochondrial dysfunction via the cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11) pathway.

Materials and methods

In db/db mice, inflammatory damage; glucose tolerance; and the expression of SLC7A11, glutathione peroxidase 4 (GPX4), and long-chain acyl-CoA synthetase family member 4 (ACSL4) were detected after treatment with Trolline. An HG-induced human microvascular endothelial cell (HMEC-1) injury model was established in vitro. Fe2+ deposition and GSH levels serve as important indicators of ferroptosis. The mitochondrial membrane potential and the cytoskeleton were determined by JC-1 and F-actin staining, respectively. The levels of apoptosis, cell cycle and reactive oxygen species (ROS) were determined by flow cytometry. Oxidative stress levels were assessed by measuring malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity. Ferroptosis- and inflammation-related protein expression in HMEC-1 cells was verified by Western blotting.

Results

In vivo experiments revealed that Trolline can lower blood sugar levels, alleviate inflammatory damage, and regulate the expression of ferroptosis-related proteins in db/db mice. In vitro experiments demonstrated that Trolline can alleviate various effects induced by HG. Under HG conditions, Trolline can inhibit apoptosis, reverse the cell cycle arrest in the SubG1 phase, reduce oxidative stress levels and Fe2+ overload, restore mitochondrial function, promote cytoskeletal remodelling, and regulate the expression of ferroptosis-related proteins. Mechanistically, ferroptosis inhibitors (Ferrostatin-1) and Trolline have the same protective effect on HMEC-1 cells in an HG environment. However, overexpression of SLC7A11 led to loss of the inhibitory effect of Trolline on ferroptosis, which confirms that the effect of Trolline is dependent on the SLC7A11-ferroptosis axis.

Conclusion

Trolline can alleviate diabetic vascular damage through SLC7A11-mediated inhibition of ferroptosis, improved mitochondrial function, and reduced oxidative inflammatory damage, providing a basis for the treatment of diabetic vascular complications.
目的:本研究探讨天然化合物Trolline通过胱氨酸/谷氨酸反转运蛋白溶质载体家族7成员11 (SLC7A11)途径缓解高糖(HG)诱导的血管内皮铁垂症和线粒体功能障碍的治疗潜力。材料与方法:db/db小鼠,炎性损伤;葡萄糖耐量;经Trolline处理后检测SLC7A11、谷胱甘肽过氧化物酶4 (GPX4)、长链酰基辅酶a合成酶家族成员4 (ACSL4)的表达。建立hg诱导的人微血管内皮细胞(HMEC-1)体外损伤模型。Fe2+沉积和GSH水平是铁下垂的重要指标。JC-1染色测定线粒体膜电位,F-actin染色测定细胞骨架。流式细胞术检测细胞凋亡、细胞周期及活性氧(ROS)水平。通过测量丙二醛(MDA)水平和超氧化物歧化酶(SOD)活性来评估氧化应激水平。Western blotting证实HMEC-1细胞中铁下垂和炎症相关蛋白的表达。结果:体内实验显示,巨魔碱能降低db/db小鼠的血糖水平,减轻炎症损伤,调节铁中毒相关蛋白的表达。体外实验表明,Trolline可以缓解HG诱导的多种作用,在HG条件下,Trolline可以抑制细胞凋亡,逆转细胞周期停滞在SubG1期,降低氧化应激水平和Fe2+超载,恢复线粒体功能,促进细胞骨架重塑,调节铁中毒相关蛋白的表达。在机制上,铁下垂抑制剂(Ferrostatin-1)和Trolline对HG环境中的HMEC-1细胞具有相同的保护作用。然而,SLC7A11的过表达导致Trolline对铁下垂的抑制作用丧失,这证实了Trolline的作用依赖于SLC7A11-铁下垂轴。结论:巨罗林可通过slc7a11介导的抑制上铁,改善线粒体功能,减轻氧化性炎症损伤,为糖尿病血管并发症的治疗提供依据。
{"title":"Trolline attenuates diabetic vascular injury by regulating SLC7A11-mediated ferroptosis and mitochondrial dysfunction","authors":"Wenbo Liu ,&nbsp;Cuifang Lu ,&nbsp;Bin Yang ,&nbsp;Ying Liu ,&nbsp;Jie Yan ,&nbsp;Tingyu Song ,&nbsp;Xiaofei Wang","doi":"10.1016/j.gene.2025.149968","DOIUrl":"10.1016/j.gene.2025.149968","url":null,"abstract":"<div><h3>Aims</h3><div>This study investigated the therapeutic potential of Trolline, a natural compound, for alleviating high-glucose (HG)-induced vascular endothelial ferroptosis and mitochondrial dysfunction via the cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11) pathway.</div></div><div><h3>Materials and methods</h3><div>In db/db mice, inflammatory damage; glucose tolerance; and the expression of SLC7A11, glutathione peroxidase 4 (GPX4), and long-chain acyl-CoA synthetase family member 4 (ACSL4) were detected after treatment with Trolline. An HG-induced human microvascular endothelial cell (HMEC-1) injury model was established in vitro. Fe<sup>2+</sup> deposition and GSH levels serve as important indicators of ferroptosis. The mitochondrial membrane potential and the cytoskeleton were determined by JC-1 and F-actin staining, respectively. The levels of apoptosis, cell cycle and reactive oxygen species (ROS) were determined by flow cytometry. Oxidative stress levels were assessed by measuring malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity. Ferroptosis- and inflammation-related protein expression in HMEC-1 cells was verified by Western blotting.</div></div><div><h3>Results</h3><div>In vivo experiments revealed that Trolline can lower blood sugar levels, alleviate inflammatory damage, and regulate the expression of ferroptosis-related proteins in db/db mice. In vitro experiments demonstrated that Trolline can alleviate various effects induced by HG. Under HG conditions, Trolline can inhibit apoptosis, reverse the cell cycle arrest in the SubG1 phase, reduce oxidative stress levels and Fe<sup>2+</sup> overload, restore mitochondrial function, promote cytoskeletal remodelling, and regulate the expression of ferroptosis-related proteins. Mechanistically, ferroptosis inhibitors (Ferrostatin-1) and Trolline have the same protective effect on HMEC-1 cells in an HG environment. However, overexpression of SLC7A11 led to loss of the inhibitory effect of Trolline on ferroptosis, which confirms that the effect of Trolline is dependent on the SLC7A11-ferroptosis axis.</div></div><div><h3>Conclusion</h3><div>Trolline can alleviate diabetic vascular damage through SLC7A11-mediated inhibition of ferroptosis, improved mitochondrial function, and reduced oxidative inflammatory damage, providing a basis for the treatment of diabetic vascular complications.</div></div>","PeriodicalId":12499,"journal":{"name":"Gene","volume":"981 ","pages":"Article 149968"},"PeriodicalIF":2.4,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The expanding role of Furin in human Disease: A comprehensive review 呋喃在人类疾病中作用的扩大:综述。
IF 2.4 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-05 Epub Date: 2025-12-19 DOI: 10.1016/j.gene.2025.149969
Xinyang Li , Chong Liu , Haidi Hu
Furin is a calcium-dependent serine endoprotease that activates multiple substrates by cleaving at polybasic motifs, playing a pivotal role in human physiology and pathology. This review summarizes the latest research progress regarding Furin’s extensive involvement in infectious diseases, tumor diseases, cardiovascular diseases, neurodegenerative diseases, metabolic diseases, and autoimmune diseases. This review offers an in-depth analysis of Furin’s dual functions, which include promoting viral entry into host cells, driving oncogenesis via growth factors, metalloproteinases, and the Notch signaling pathway, and maintaining metabolic homeostasis and immune tolerance. Key pathophysiological mechanisms involve the dysfunction of Furin substrate activation in atherosclerosis, hypertension, Alzheimer’s disease, diabetes, and other disorders. The review also highlights the potential value of Furin as a diagnostic and prognostic biomarker and therapeutic target, while pointing out the challenges encountered in developing its inhibitors.
Furin是一种钙依赖性丝氨酸内蛋白酶,可通过切割多基序激活多种底物,在人体生理和病理中发挥关键作用。本文综述了Furin在感染性疾病、肿瘤疾病、心血管疾病、神经退行性疾病、代谢性疾病和自身免疫性疾病中广泛应用的最新研究进展。这篇综述深入分析了Furin的双重功能,包括促进病毒进入宿主细胞,通过生长因子、金属蛋白酶和Notch信号通路驱动肿瘤发生,以及维持代谢稳态和免疫耐受。在动脉粥样硬化、高血压、阿尔茨海默病、糖尿病和其他疾病中,关键的病理生理机制涉及Furin底物激活功能障碍。该综述还强调了Furin作为诊断和预后生物标志物和治疗靶点的潜在价值,同时指出了开发其抑制剂所面临的挑战。
{"title":"The expanding role of Furin in human Disease: A comprehensive review","authors":"Xinyang Li ,&nbsp;Chong Liu ,&nbsp;Haidi Hu","doi":"10.1016/j.gene.2025.149969","DOIUrl":"10.1016/j.gene.2025.149969","url":null,"abstract":"<div><div>Furin is a calcium-dependent serine endoprotease that activates multiple substrates by cleaving at polybasic motifs, playing a pivotal role in human physiology and pathology. This review summarizes the latest research progress regarding Furin’s extensive involvement in infectious diseases, tumor diseases, cardiovascular diseases, neurodegenerative diseases, metabolic diseases, and autoimmune diseases. This review offers an in-depth analysis of Furin’s dual functions, which include promoting viral entry into host cells, driving oncogenesis via growth factors, metalloproteinases, and the Notch signaling pathway, and maintaining metabolic homeostasis and immune tolerance. Key pathophysiological mechanisms involve the dysfunction of Furin substrate activation in atherosclerosis, hypertension, Alzheimer’s disease, diabetes, and other disorders. The review also highlights the potential value of Furin as a diagnostic and prognostic biomarker and therapeutic target, while pointing out the challenges encountered in developing its inhibitors.</div></div>","PeriodicalId":12499,"journal":{"name":"Gene","volume":"981 ","pages":"Article 149969"},"PeriodicalIF":2.4,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gene
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1